(AIH) was the first liver disease for which an effective therapeutic intervention, corticosteroid treatment, was convincingly demonstrated in controlled clinical trials.
However, 50 years later AIH still remains a major diagnostic and therapeutic challenge.
Read the newly released EASL CPGs to learn more
|Join the Community Portal conversation on Autoimmune Hepatitis
Login and express your ideas. Perhaps there is an area of the new CPGs that needs more explanation or that you wish to discuss? The liver community wants to hear your thoughts.
Are you a young investigator?
Do you need financial support for your liver research? Experience up to 3 months in a host #European institution exchanging your liver study and science courtesy of EASL. The Andrew K. Burroughs short-term training fellowship programme is there to help.
Apply before 15 September 2015!
The annual EASL meeting is where the global liver community comes together.
Take a trip down memory lane, and revisit ILC 2015 highlights video
. Watch, share, like, and spread the word to let your colleagues, peers, young fellows, and contacts know that it’s out there!
The ILC 2016 website will go live 1 October 2015 so mark your diary and sign-up here
to get notified when more info is available. Tell your peers to do so too!